The program allows safety-net providers to obtain discounted medications. Disproportionate share hospitals accounted for the largest share of purchases, totaling $51.9 million. Other key purchasers were health center programs ($3.6 billion), children’s hospitals ($2.1 billion), sexually transmitted disease clinics ($1.7 billion), and clinics funded by the Ryan White HIV/AIDS program ($1.5 billion).
High-cost pharmaceuticals purchased through specialty channels made up 60.6% of total 340B purchases, although they accounted for only 36% of units purchased, according to the data.
